Lytgobi to treat intrahepatic cholangiocarcinoma
Drug Name: Lytgobi Active Ingredient: futibatinib Indications: To treat intrahepatic cholangiocarcinoma harboring fibroblast growth factor receptor 2 (FGFR2) gene fusions or other rearrangements Approval Date: 9/30/2022 Company: Taiho Oncology, Inc…